;PMID: 7830489
;source_file_2963.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..30] = [t:0..30]
;1)sentence:[e:36..93] = [t:36..93]
;2)section:[e:97..141] = [t:97..141]
;3)section:[e:145..185] = [t:145..185]
;4)sentence:[e:189..289] = [t:189..289]
;5)sentence:[e:290..416] = [t:290..416]
;6)sentence:[e:417..735] = [t:417..735]
;7)sentence:[e:736..833] = [t:736..833]
;8)sentence:[e:834..1054] = [t:834..1054]
;9)sentence:[e:1055..1129] = [t:1055..1129]
;10)sentence:[e:1130..1262] = [t:1130..1262]
;11)sentence:[e:1263..1479] = [t:1263..1479]
;12)section:[e:1483..1527] = [t:1483..1527]

;section 0 Span:0..30
;Life Sci.  1995;56(1):PL19-25.
(SEC
  (FRAG (NNP:[0..4] Life) (NNP:[5..8] Sci) (.:[8..9] .) (CD:[11..15] 1995)
        (::[15..16] ;) (CD:[16..18] 56) (-LRB-:[18..19] -LRB-) (CD:[19..20] 1)
        (-RRB-:[20..21] -RRB-) (::[21..22] :) (NN:[22..29] PL19-25)
        (.:[29..30] .)))

;sentence 1 Span:36..93
;Adrenomedullin mediates vasodilation via CGRP1 receptors.
;[36..50]:gene-protein:"Adrenomedullin"
;[77..92]:gene-protein:"CGRP1 receptors"
(SENT
  (S-HLN
    (NP-SBJ (NN:[36..50] Adrenomedullin))
    (VP (VBZ:[51..59] mediates)
      (NP (NN:[60..72] vasodilation))
      (PP-MNR (IN:[73..76] via)
        (NP (NN:[77..82] CGRP1) (NNS:[83..92] receptors))))
    (.:[92..93] .)))

;section 2 Span:97..141
;Entzeroth M, Doods HN, Wieland HA, Wienen W.
(SEC
  (FRAG (NNP:[97..106] Entzeroth) (NNP:[107..108] M) (,:[108..109] ,)
        (NNP:[110..115] Doods) (NNP:[116..118] HN) (,:[118..119] ,)
        (NNP:[120..127] Wieland) (NNP:[128..130] HA) (,:[130..131] ,)
        (NNP:[132..138] Wienen) (NNP:[139..140] W) (.:[140..141] .)))

;section 3 Span:145..185
;Dr. Karl Thomae GmbH, Biberach, Germany.
(SEC
  (FRAG (NNP:[145..147] Dr) (.:[147..148] .) (NNP:[149..153] Karl)
        (NNP:[154..160] Thomae) (NNP:[161..165] GmbH) (,:[165..166] ,)
        (NNP:[167..175] Biberach) (,:[175..176] ,) (NNP:[177..184] Germany)
        (.:[184..185] .)))

;sentence 4 Span:189..289
;Adrenomedullin is a recently discovered 52 amino acid polypeptide with potent
; hypotensive activity.
;[189..203]:gene-protein:"Adrenomedullin"
(SENT
  (S
    (NP-SBJ (NN:[189..203] Adrenomedullin))
    (VP (VBZ:[204..206] is)
      (NP-PRD
        (NP (DT:[207..208] a)
          (ADJP (RB:[209..217] recently) (VBN:[218..228] discovered))
          (NML (CD:[229..231] 52) (JJ:[232..237] amino) (NN:[238..242] acid))
          (NN:[243..254] polypeptide))
        (PP (IN:[255..259] with)
          (NP (JJ:[260..266] potent) (JJ:[268..279] hypotensive)
              (NN:[280..288] activity)))))
    (.:[288..289] .)))

;sentence 5 Span:290..416
;The peptide possesses 21% homology with the amino acid  sequence of human
;calcitonin gene-related peptide-alpha (hCGRP-alpha).
;[364..401]:gene-protein:"calcitonin gene-related peptide-alpha"
;[403..414]:gene-protein:"hCGRP-alpha"
(SENT
  (S
    (NP-SBJ (DT:[290..293] The) (NN:[294..301] peptide))
    (VP (VBZ:[302..311] possesses)
      (NP
        (NP
          (NML (CD:[312..314] 21) (NN:[314..315] %))
          (NN:[316..324] homology))
        (PP (IN:[325..329] with)
          (NP
            (NP (DT:[330..333] the)
              (NML (JJ:[334..339] amino) (NN:[340..344] acid))
              (NN:[346..354] sequence))
            (PP (IN:[355..357] of)
              (NP
                (NP (JJ:[358..363] human)
                   (NN:[364..374] calcitonin)
                  (ADJP (NN:[375..379] gene) (HYPH:[379..380] -)
                        (VBN:[380..387] related))
                  (SYM:[388..401] peptide-alpha))
                (NP (-LRB-:[402..403] -LRB-) (NN:[403..414] hCGRP-alpha)
                    (-RRB-:[414..415] -RRB-))))))))
    (.:[415..416] .)))

;sentence 6 Span:417..735
;In  125I-hCGRP-alpha receptor binding experiments using membranes from human 
;neuroblastoma cells (SK-N-MC) adrenomedullin is a potent competitor with a Ki
;of  0.37 nM. In SK-N-MC cells hCGRP-alpha and adrenomedullin 
;concentration-dependently increase cAMP levels with -logEC50 values of 9.65
;and  7.75, respectively.
;[421..446]:gene-protein:"125I-hCGRP-alpha receptor"
;[495..508]:malignancy-type:"neuroblastoma"
;[525..539]:gene-protein:"adrenomedullin"
;[603..614]:gene-protein:"hCGRP-alpha"
;[619..633]:gene-protein:"adrenomedullin"
(SENT
  (S
    (PP (IN:[417..419] In)
      (NP
        (NP
          (NML (NN:[421..437] 125I-hCGRP-alpha) (NN:[438..446] receptor))
          (NN:[447..454] binding) (NNS:[455..466] experiments))
        (VP (VBG:[467..472] using)
          (NP
            (NP (NNS:[473..482] membranes))
            (PP (IN:[483..487] from)
              (NP (JJ:[488..493] human) (NN:[495..508] neuroblastoma)
                  (NNS:[509..514] cells)))
            (PRN (-LRB-:[515..516] -LRB-)
              (NP (NN:[516..523] SK-N-MC))
              (-RRB-:[523..524] -RRB-))))))
    (NP-SBJ (NN:[525..539] adrenomedullin))
    (VP (VBZ:[540..542] is)
      (NP-PRD
        (NP (DT:[543..544] a) (JJ:[545..551] potent) (NN:[552..562] competitor))
        (PP (IN:[563..567] with)
          (NP
            (NP (DT:[568..569] a) (NN:[570..572] Ki))
            (PP (IN:[573..575] of)
              (NP (CD:[577..581] 0.37) (NN:[582..584] nM)))))))
    (.:[584..585] .))
  (S
    (PP-LOC (IN:[586..588] In)
      (NP (NN:[589..596] SK-N-MC) (NNS:[597..602] cells)))
    (NP-SBJ (NN:[603..614] hCGRP-alpha) (CC:[615..618] and)
            (NN:[619..633] adrenomedullin))
    (ADVP (NN:[635..648] concentration) (HYPH:[648..649] -)
          (RB:[649..660] dependently))
    (VP (VBP:[661..669] increase)
      (NP
        (NP (NN:[670..674] cAMP) (NNS:[675..681] levels))
        (PP (IN:[682..686] with)
          (NP
            (NP (NN:[687..695] -logEC50) (NNS:[696..702] values))
            (PP (IN:[703..705] of)
              (NP (CD:[706..710] 9.65) (CC:[711..714] and) (CD:[716..720] 7.75))))))
      (,:[720..721] ,)
      (ADVP (RB:[722..734] respectively)))
    (.:[734..735] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[417..735]::S:S:

;sentence 7 Span:736..833
;Both responses were attenuated in the presence of 30 nM  CGRP[8-37], a CGRP1
;receptor antagonist.
;[807..821]:gene-protein:"CGRP1 receptor"
(SENT
  (S
    (NP-SBJ-1 (DT:[736..740] Both) (NNS:[741..750] responses))
    (VP (VBD:[751..755] were)
      (VP (VBN:[756..766] attenuated)
        (NP-1 (-NONE-:[766..766] *))
        (PP (IN:[767..769] in)
          (NP
            (NP (DT:[770..773] the) (NN:[774..782] presence))
            (PP (IN:[783..785] of)
              (NP
                (NP (CD:[786..788] 30) (NN:[789..791] nM)
                    (NN:[793..803] CGRP-LSB-8-37-RSB-))
                (,:[803..804] ,)
                (NP (DT:[805..806] a)
                  (NML (NN:[807..812] CGRP1) (NN:[813..821] receptor))
                  (NN:[822..832] antagonist))))))))
    (.:[832..833] .)))

;sentence 8 Span:834..1054
;In isolated rat hearts, perfused at  constant flow, bolus infusion of
;adrenomedullin (1 to 100 nM) resulted in a  concentration-dependent,
;pronounced and long-lasting vasodilation with an  approximate EC50 of about 3
;nM.
;[904..918]:gene-protein:"adrenomedullin"
(SENT
  (S
    (PP-LOC (IN:[834..836] In)
      (NP
        (NP (VBN:[837..845] isolated) (NN:[846..849] rat)
            (NNS:[850..856] hearts))
        (,:[856..857] ,)
        (VP (VBN:[858..866] perfused)
          (NP (-NONE-:[866..866] *))
          (PP (IN:[867..869] at)
            (NP (JJ:[871..879] constant) (NN:[880..884] flow))))))
    (,:[884..885] ,)
    (NP-SBJ
      (NP (NN:[886..891] bolus) (NN:[892..900] infusion))
      (PP (IN:[901..903] of)
        (NP (NN:[904..918] adrenomedullin)
          (PRN (-LRB-:[919..920] -LRB-)
            (NP
              (QP (CD:[920..921] 1) (TO:[922..924] to) (CD:[925..928] 100))
              (NN:[929..931] nM))
            (-RRB-:[931..932] -RRB-)))))
    (VP (VBD:[933..941] resulted)
      (PP-CLR (IN:[942..944] in)
        (NP (DT:[945..946] a)
          (ADJP
            (ADJP (NN:[948..961] concentration) (HYPH:[961..962] -)
                  (JJ:[962..971] dependent))
            (,:[971..972] ,)
            (ADJP (JJ:[973..983] pronounced))
            (CC:[984..987] and)
            (ADJP (JJ:[988..992] long) (HYPH:[992..993] -)
                  (VBG:[993..1000] lasting)))
          (NN:[1001..1013] vasodilation)))
      (PP (IN:[1014..1018] with)
        (NP
          (NP (DT:[1019..1021] an) (JJ:[1023..1034] approximate)
              (NN:[1035..1039] EC50))
          (PP (IN:[1040..1042] of)
            (NP
              (QP (RB:[1043..1048] about) (CD:[1049..1050] 3))
              (NN:[1051..1053] nM))))))
    (.:[1053..1054] .)))

;sentence 9 Span:1055..1129
;This effect was markedly attenuated in the  presence of 100 nM CGRP[8-37].
(SENT
  (S
    (NP-SBJ-1 (DT:[1055..1059] This) (NN:[1060..1066] effect))
    (VP (VBD:[1067..1070] was)
      (ADVP (RB:[1071..1079] markedly))
      (VP (VBN:[1080..1090] attenuated)
        (NP-1 (-NONE-:[1090..1090] *))
        (PP (IN:[1091..1093] in)
          (NP
            (NP (DT:[1094..1097] the) (NN:[1099..1107] presence))
            (PP (IN:[1108..1110] of)
              (NP
                (NML (CD:[1111..1114] 100) (NN:[1115..1117] nM))
                (NN:[1118..1128] CGRP-LSB-8-37-RSB-)))))))
    (.:[1128..1129] .)))

;sentence 10 Span:1130..1262
;In this model, bolus infusion of hCGRP-alpha  (0.01 to 100 nM) evoked a
;comparable vasodilation with an approximate EC50 of  0.5 nM.
;[1163..1174]:gene-protein:"hCGRP-alpha"
(SENT
  (S
    (PP (IN:[1130..1132] In)
      (NP (DT:[1133..1137] this) (NN:[1138..1143] model)))
    (,:[1143..1144] ,)
    (NP-SBJ
      (NP (NN:[1145..1150] bolus) (NN:[1151..1159] infusion))
      (PP (IN:[1160..1162] of)
        (NP (NN:[1163..1174] hCGRP-alpha)))
      (PRN (-LRB-:[1176..1177] -LRB-)
        (NP
          (QP (CD:[1177..1181] 0.01) (TO:[1182..1184] to) (CD:[1185..1188] 100))
          (NN:[1189..1191] nM))
        (-RRB-:[1191..1192] -RRB-)))
    (VP (VBD:[1193..1199] evoked)
      (NP (DT:[1200..1201] a) (JJ:[1202..1212] comparable)
          (NN:[1213..1225] vasodilation))
      (PP (IN:[1226..1230] with)
        (NP
          (NP (DT:[1231..1233] an) (JJ:[1234..1245] approximate)
              (NN:[1246..1250] EC50))
          (PP (IN:[1251..1253] of)
            (NP (CD:[1255..1258] 0.5) (NN:[1259..1261] nM))))))
    (.:[1261..1262] .)))

;sentence 11 Span:1263..1479
;This effect was also potently inhibited in the presence of CGRP[8-37].  These
;results suggest that adrenomedullin-mediated vasodilation is linked to the 
;activation of CGRP1 receptors in the coronary vascular system.
;[1362..1376]:gene-protein:"adrenomedullin"
;[1431..1446]:gene-protein:"CGRP1 receptors"
(SENT
  (S
    (S
      (NP-SBJ-1 (DT:[1263..1267] This) (NN:[1268..1274] effect))
      (VP (VBD:[1275..1278] was)
        (ADVP (RB:[1279..1283] also))
        (ADVP (RB:[1284..1292] potently))
        (VP (VBN:[1293..1302] inhibited)
          (NP-1 (-NONE-:[1302..1302] *))
          (PP (IN:[1303..1305] in)
            (NP
              (NP (DT:[1306..1309] the) (NN:[1310..1318] presence))
              (PP (IN:[1319..1321] of)
                (NP (NN:[1322..1332] CGRP-LSB-8-37-RSB-)))))))
      (.:[1332..1333] .))
    (S
      (NP-SBJ (DT:[1335..1340] These) (NNS:[1341..1348] results))
      (VP (VBP:[1349..1356] suggest)
        (SBAR (IN:[1357..1361] that)
          (S
            (NP-SBJ-2
              (ADJP (NN:[1362..1376] adrenomedullin) (HYPH:[1376..1377] -)
                    (VBN:[1377..1385] mediated))
              (NN:[1386..1398] vasodilation))
            (VP (VBZ:[1399..1401] is)
              (VP (VBN:[1402..1408] linked)
                (NP-2 (-NONE-:[1408..1408] *))
                (PP (TO:[1409..1411] to)
                  (NP
                    (NP (DT:[1412..1415] the) (NN:[1417..1427] activation))
                    (PP (IN:[1428..1430] of)
                      (NP (NN:[1431..1436] CGRP1)
                        (NML (NNS:[1437..1446] receptors))))
                    (PP (IN:[1447..1449] in)
                      (NP (DT:[1450..1453] the) (JJ:[1454..1462] coronary)
                          (JJ:[1463..1471] vascular) (NN:[1472..1478] system)))))))))))
    (.:[1478..1479] .)))

;section 12 Span:1483..1527
;PMID: 7830489 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1483..1487] PMID) (::[1487..1488] :) (CD:[1489..1496] 7830489)
        (NN:[1497..1498] -LSB-) (NNP:[1498..1504] PubMed) (::[1505..1506] -)
        (NN:[1507..1514] indexed) (IN:[1515..1518] for)
        (NNP:[1519..1526] MEDLINE) (-RRB-:[1526..1527] -RSB-)))
